Document is current
Any future updates will be listed below
-
Authors
Nishikori, Momoko https://orcid.org/0000-0003-4171-2162
Masaki, Yasufumi
Fujii, Nobuharu
Ikeda, Takashi
Takahara-Matsubara, Mariko
Sugimoto, Saori
Kondo, Eisei
-
Funding
Funding for this research was provided by:
dainippon sumitomo pharma
- License Information
-
More Information
Article History
Received: 16 July 2021
Revised: 14 November 2021
Accepted: 14 November 2021
First Online: 26 November 2021
Declarations
:
: YM has received research grants from Kyowa Kirin Pharma, Astellas Pharma, Eisai Pharma, Ono Pharma, Pfizer Pharma, Asahi Kasei Pharma, MSD Pharma, Daiichi-Sankyo Pharma, Taisho Pharma, Taiho Pharma, Takeda Pharma, Chugai Pharma, Teijin Pharma, Nippon Kayaku, and Mochida Pharma, outside the submitted work. MT and SS are employees of Sumitomo Dainippon Pharma Co., Ltd. EK received honoraria from Sumitomo Dainippon Pharma and Otsuka. MN, NF, TI, have nothing to declare.
